Skip to main content
Equibles
PAVM logo

PAVM · PAVmed Inc. · Webcasts, Transcripts & Audio

Track PAVM — free

Use PAVM with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research PAVM.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$2.66 -0.21 (-7.32%) At close · Oct 5
Rebalance outlook locked
Going-concern doubt — flagged Aug 13, 2026

Substantial doubt about the company's ability to continue as a going concern.

“These factors raise substantial doubt about the Company's ability to continue as a going concern within one year after the date the accompanying unaudited condensed consolidated financial statements are issued.”
View the 10-Q filed Aug 13, 2026
Market Cap
$30.74M
Shares
8.00M
Volume · Oct 5 7390 Avg daily vol (3M) 30.28K

PAVmed Inc. Webcasts

Earnings calls, investor updates, investor days and conferences for PAVmed Inc. (PAVM), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.

Pull transcripts and briefs through the earnings call transcript API or MCP →

Revenue & result across quarters

Revenue Net income YoY up YoY down artefacts
▼62% $76,000 −$26.13M '22 Q3 22-11-15 ▲136% $446,000 −$17.93M '23 Q1 23-03-31 · $166,000 −$14.54M '23 Q2 23-06-30 ▲940.8% $791,000 −$17.67M '23 Q3 23-11-15 · $1.10M −$14.04M '23 Q4 23-12-31 ▲124.2% $1.00M −$15.21M '24 Q1 24-05-14 ▲502.4% $1.00M −$10.83M '24 Q2 24-08-13 ▲26.4% $1.00M $64.40M '24 Q3 24-11-14 ▼100% $ $1.43M '24 Q4 25-03-25 ▼99.2% $8,000 $18.97M '25 Q1 25-05-15 ▼99.4% $6,000 −$11.92M '25 Q2 25-08-14 ▼99.5% $5,000 −$5.38M '25 Q3 25-11-13 · $52,000 −$1.26M '25 Q4 26-03-30 ▲175% $22,000 −$60,000 '26 Q1 26-05-15 LATEST ▲450% $33,000 −$5.38M '26 Q2 26-08-14
Earnings call
FY26 · Q2
2026-08-14
PAVmed Inc. (PAVM) Q2 2026 Earnings Call Transcript
Positive tone Lucid Diagnostics reimbursement and equity value PortIO regulatory and clinical progress Liquidity and balance sheet
Revenue
$33,000
▲ 450% YoY
Diluted EPS
$-0.87
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY26 · Q1
2026-05-15
PAVmed Inc. (PAVM) Q1 2026 Earnings Call Transcript
Confident tone Capital structure restructuring Medical device portfolio relaunch Veris commercial rollout at OSU
Revenue
$22,000
▲ 175% YoY
Diluted EPS
$-4.42
▼ 143.8% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q4
2026-03-30
PAVmed Inc. (PAVM) Q4 2025 Earnings Call Transcript
Confident tone Capital restructuring and balance sheet MedTech portfolio relaunch and Duke imaging technology Veris Health commercial launch with OSU
Revenue
$52,000*
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY25 · Q3
2025-11-13
PAVmed Inc. (PAVM) Q3 2025 Earnings Call Transcript
Confident tone Lucid Diagnostics / EsoGuard commercialization Veris Cancer Care platform and OSU partnership Implantable physiologic monitor / FDA submission
Revenue
$5,000
▼ 99.5% YoY
Diluted EPS
$-8.70
▼ 120.1% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q2
2025-08-14
PAVmed Inc. (PAVM) Q2 2025 Earnings Call
Revenue
$6,000
▼ 99.4% YoY
Diluted EPS
$-22.08
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q1
2025-05-15
PAVmed Inc. (PAVM) Q1 2025 Earnings Call Transcript
Confident tone Lucid Diagnostics / e-cigars Veris Health / digital health Balance sheet / financing
Revenue
$8,000
▼ 99.2% YoY
Diluted EPS
$10.10
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q4
2025-03-25
PAVmed Inc. (PAVM) Q4 2024 Earnings Call
Revenue
$*
▼ 100% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY24 · Q3
2024-11-14
PAVmed Inc. (PAVM) Q3 2024 Earnings Call Transcript
Positive tone Corporate restructuring and balance sheet PMX incubator and PortIO device Listing compliance risk
Revenue
$1.00M
▲ 26.4% YoY
Diluted EPS
$43.20
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q2
2024-08-13
PAVmed Inc. (PAVM) Q2 2024 Earnings Call Transcript
Positive tone Veris Health pilot and financing PMX Incubator / PortIO financing Lucid Diagnostics / EsoGuard commercial progress
Revenue
$1.00M
▲ 502.4% YoY
Diluted EPS
$-35.70
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q1
2024-05-14
PAVmed Inc. (PAVM) Q1 2024 Earnings Call Transcript
Positive tone Lucid and EsoGuard commercial progress Veris Health pilot at Ohio State PMX Incubator and PortIO
Revenue
$1.00M
▲ 124.2% YoY
Diluted EPS
$-78.60
Rev · 7q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q4
2023-12-31
PAVmed Inc. (PAVM) Q4 2023 Earnings Call Transcript
Revenue
$1.10M*
Rev · 6q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY23 · Q3
2023-11-15
PAVmed Inc. (PAVM) Q3 2023 Earnings Call Transcript
Revenue
$791,000
▲ 940.8% YoY
Diluted EPS
$-71.40
Rev · 6q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q2
2023-06-30
PAVmed Inc. (PAVM) Q2 2023 Earnings Call Transcript
Revenue
$166,000
Diluted EPS
$-63.00
Rev · 5q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q1
2023-03-31
PAVmed Inc. (PAVM) Q1 2023 Earnings Call Transcript
Revenue
$446,000
▲ 136% YoY
Diluted EPS
$-83.40
Rev · 4q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q4
2023-03-15
PAVmed Inc. (PAVM) Q4 2022 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY22 · Q3
2022-11-15
PAVmed Inc. (PAVM) Q3 2022 Earnings Call Transcript
Revenue
$76,000
▼ 62% YoY
Diluted EPS
$-130.50
Rev · 3q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q2
2022-08-17
PAVmed Inc. (PAVM) Q2 2022 Earnings Call Transcript
Diluted EPS
$-130.50
Rev · 2q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q1
2022-05-12
PAVmed Inc. (PAVM) Q1 2022 Earnings Call Transcript
Revenue
$189,000
Gross margin
-95.2%
Rev · 2q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q4
2022-03-29
PAVmed Inc. (PAVM) Q4 2021 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY21 · Q3
2021-11-04
PAVmed Inc. (PAVM) Q3 2021 Earnings Call Transcript
Revenue
$200,000
Gross margin
28.0%
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q2
2021-08-12
PAVmed Inc. (PAVM) Q2 2021 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q1
2021-05-17
PAVmed Inc. (PAVM) Q1 2021 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q4
2021-02-22
PAVmed Inc. (PAVM) Q4 2020 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY20 · Q3
2020-11-17
PAVmed Inc. (PAVM) Q3 2020 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q2
2020-08-18
PAVmed Inc. (PAVM) Q2 2020 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q1
2020-05-21
PAVmed Inc. (PAVM) Q1 2020 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-Q
Showing 1–26 of 26 webcasts
Key facts CIK 1624326 CUSIP 70387R502 Visit website Investor relations